Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
eLife · 2024
DOI: 10.7554/elife.87458 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Yufang Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, United States. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas A and M University, Tufts University.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries. There is growing evidence that dysbiosis of the intestinal microbiota and disruption of microbiota-host interactions contribute to the pathology of NAFLD. We previously demonstrated that gut microbiota-derived tryptophan metabolite indole-3-acetate (I3A) was decreased in both cecum and liver of high-fat diet-fed mice and attenuated the expression of inflammatory cytokines in macrophages and Tnfa and fatty acid-induced inflammatory responses in an aryl-hydrocarbon receptor (AhR)-dependent manner in hepatocytes. In this study, we investigated the effect of orally administered I3A in a mouse model of diet-induced NAFLD. Western diet (WD)-fed mice given sugar water (SW) with I3A showed dramatically decreased serum ALT, hepatic triglycerides (TG), liver steatosis, hepatocyte ballooning, lobular inflammation, and hepatic production of inflammatory cytokines, compared to WD-fed mice given only SW. Metagenomic analysis show that I3A administration did not significantly modify the intestinal microbiome, suggesting that I3A’s beneficial effects likely reflect the metabolite’s direct actions on the liver. Administration of I3A partially reversed WD-induced alterations of liver metabolome and proteome, notably, decreasing expression of several enzymes in hepatic lipogenesis and β-oxidation. Mechanistically, we also show that AMP-activated protein kinase (AMPK) mediates the anti-inflammatory effects of I3A in macrophages. The potency of I3A in alleviating liver steatosis and inflammation clearly demonstrates its potential as a therapeutic modality for preventing the progression of steatosis to non-alcoholic steatohepatitis (NASH).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, United States.
- Department of Chemical and Biological Engineering, Tufts University, Medford, United States.
- Department of Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, United States.
- Department of Microbial Pathogenesis and Immunology, College of Medicine, Texas Health Science Center, Texas A&M University, Bryan, United States.
ORCID-Profile: Yufang Ding, Arul Jayaraman
Förderung
- Texas A and M University
- Tufts University
Zitieren
APA
Ding, Y., Yanagi, K., Yang, F., Callaway, E., Cheng, C., Hensel, M. E., Menon, R., Alaniz, R. C., Lee, K., & Jayaraman, A. (2024). Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. eLife. https://doi.org/10.7554/elife.87458
Vancouver
Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, et al. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice. eLife. 2024. doi:10.7554/elife.87458
BibTeX
@article{Ding2024,
author = {Ding, Yufang and Yanagi, Karin and Yang, Fang and Callaway, Evelyn and Cheng, Clint and Hensel, Martha E and Menon, Rani and Alaniz, Robert C and Lee, Kyongbum and Jayaraman, Arul},
title = {Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.87458}
}
EUVIMED